Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces it has closed its previously announced inaugural private placement offering (the "Offering") of $150 million aggregate principal amount of 6.875% senior unsecured notes due July 15, 2031 (the "Notes"). The Notes were issued at par under a trust indenture and are direct senior unsecured obligations of WELL and rank equally in right of payment with all other present and future senior unsecured indebtedness of the Company.
"With this offering now closed, we have the capital in hand to retire our December 2026 convertible debentures and move forward with a cleaner, more flexible balance sheet," said Hamed Shahbazi, Chairman and CEO of WELL. "We are grateful for the support we received from the Canadian institutional fixed income community, and we look forward to putting this financing to work behind our growth strategy."
As previously announced, the Company intends to use the net proceeds to fully repay its convertible debentures maturing December 2026 and for general corporate purposes.
BMO Capital Markets acted as lead bookrunner for the Offering, with RBC Capital Markets, Stifel, J.P. Morgan and TD Securities acting as joint bookrunners, Scotiabank acting as co-lead manager, and CIBC Capital Markets and ATB Cormark Capital Markets acting as co-managers.
The Notes were offered in each of the provinces of Canada on a private placement basis. The Notes were not qualified for distribution to the public or registered under the securities laws of any province or territory of Canada. The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States or to any U.S. persons.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
All amounts in Canadian dollars unless otherwise stated
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director